CatalystPit

DNAGinkgo Bioworks Holdings, Inc.

NYSE · Biological Products, (No Diagnostic Substances)
Last close $12.83 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
RECENT INSIDER TRADES
  • 2026-10-07 · Coen Steven P. (See remarks) · SELL
  • 2026-09-16 · HENRY CHRISTIAN O (Director) · SELL
  • 2026-08-25 · Coen Steven P. (See remarks) · SELL
  • 2026-07-20 · Coen Steven P. (See remarks) · SELL
  • 2026-05-26 · Coen Steven P. (See remarks) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders200
Shares held81,232,660
Value$393.92M
As of quarter end2026-06-30
RECENT NEWS
  • Araceli Biosciences and Ginkgo Bioworks integrate cellular imaging into Nebula lab system
  • Araceli Biosciences and Ginkgo Bioworks integrate cell imaging into Nebula lab loop
  • Ginkgo Bioworks integrates Araceli imaging system into lab
  • Araceli Biosciences and Ginkgo Bioworks integrate cellular imaging platform
  • From Boxabl to Ginkgo Bioworks: A Startup Advisory Practice Built on a Decade of Early Investments and Exits
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS